Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
53 results:

  • 1. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
    Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
    [No Abstract]    [Full Text] [Related]  

  • 2. PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
    Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
    Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term outcomes after endoscopic versus surgical resection of T1 colorectal carcinoma.
    Bae HJ; Ju H; Lee HH; Kim J; Lee BI; Lee SH; Won DD; Lee YS; Lee IK; Cho YS
    Surg Endosc; 2023 Feb; 37(2):1231-1241. PubMed ID: 36171453
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
    Karam E; Tabutin M; Mastier C; Crignis L; Peyrat P; Martin V; Badon F; Muller X; Meeus P; Rivoire M; Dupré A
    J Surg Oncol; 2023 Jan; 127(1):183-191. PubMed ID: 36169242
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis.
    Jiang K; Chen H; Ding K
    Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in colorectal cancer.
    Fujii S; Kotani D; Hattori M; Nishihara M; Shikanai T; Hashimoto J; Hama Y; Nishino T; Suzuki M; Yoshidumi A; Ueno M; Komatsu Y; Masuishi T; Hara H; Esaki T; Nakamura Y; Bando H; Yamada T; Yoshino T
    Clin Cancer Res; 2022 Jun; 28(12):2623-2632. PubMed ID: 35363302
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular characteristics of young-onset colorectal cancer in Vietnamese patients.
    Do MD; Nguyen TH; Le KT; Le LHG; Nguyen BH; Le KT; Doan TPT; Ho CQ; Nguyen HN; Tran TD; Vu HA
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):678-685. PubMed ID: 35098669
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. 30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes.
    Woodward ER; Green K; Burghel GJ; Bulman M; Clancy T; Lalloo F; Schlecht H; Wallace AJ; Evans DG
    Eur J Hum Genet; 2022 Apr; 30(4):413-419. PubMed ID: 34866136
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
    Gao S; Soares F; Wang S; Wong CC; Chen H; Yang Z; Liu W; Go MYY; Ahmed M; Zeng Y; O'Brien CA; Sung JJY; He HH; Yu J
    Oncogene; 2021 Dec; 40(48):6601-6613. PubMed ID: 34621019
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon.
    Fernandes MR; Rodrigues JCG; Dobbin EAF; Pastana LF; da Costa DF; Barra WF; Modesto AAC; de Assumpção PB; da Costa Silva AL; Dos Santos SEB; Burbano RMR; de Assumpção PP; Dos Santos NPC
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):837-844. PubMed ID: 34331561
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China.
    Guan X; Li H; Xiong X; Peng C; Wang N; Ma X; Ma A
    J Med Econ; 2021; 24(1):339-344. PubMed ID: 33571036
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer.
    Loft M; Wong HL; Kosmider S; Lee M; Tie J; Wong R; Jones IT; Croxford M; Steel M; Faragher I; Guerrieri M; Christie M; Gibbs P
    Intern Med J; 2021 Aug; 51(8):1262-1268. PubMed ID: 32896960
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases.
    Pangarkar S; Mistry K; Choudhari A; Smriti V; Ahuja A; Katdare A; Engineer R; Ostwal V; Ramadwar M; Saklani A; Baheti AD
    Abdom Radiol (NY); 2021 Feb; 46(2):498-505. PubMed ID: 32813028
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Low colorectal cancer survival in the Mountain West state of Nevada: A population-based analysis.
    Callahan KE; Ponce CP; Cross CL; Sy FS; Pinheiro PS
    PLoS One; 2019; 14(8):e0221337. PubMed ID: 31425558
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration.
    Fornell-Perez R; Perez-Alonso E; Porcel-de-Peralta G; Duran-Castellon A; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Orihuela-de-la-Cal ME; Loro-Ferrer JF
    Abdom Radiol (NY); 2019 Nov; 44(11):3674-3682. PubMed ID: 31332499
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prediction of Distant Recurrence Using EndoPredict Among Women with ER
    Filipits M; Dubsky P; Rudas M; Greil R; Balic M; Bago-Horvath Z; Singer CF; Hlauschek D; Brown K; Bernhisel R; Kronenwett R; Lancaster JM; Fitzal F; Gnant M
    Clin Cancer Res; 2019 Jul; 25(13):3865-3872. PubMed ID: 31064782
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.
    Guo GF; Wang YX; Zhang YJ; Chen XX; Lu JB; Wang HH; Jiang C; Qiu HQ; Xia LP
    World J Gastroenterol; 2019 Apr; 25(15):1840-1853. PubMed ID: 31057298
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Development and Validation of a Nomogram for Preoperative Prediction of Perineural Invasion in colorectal cancer.
    Huang X; Liu J; Wu G; Chen S; Pc FJ; Xie W; Tang W
    Med Sci Monit; 2019 Mar; 25():1709-1717. PubMed ID: 30837449
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survival nomograms for stage III colorectal cancer.
    Li C; Pei Q; Zhu H; Tan F; Zhou Z; Zhou Y; Li Y; Pei H
    Medicine (Baltimore); 2018 Dec; 97(49):e13239. PubMed ID: 30544384
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.